Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Study Information
Alliance Study ID: NCCTG-N00CA
NCT Study ID (ClinicalTrials.gov): NCT00033605
Disease or Cancer Type: Other Cancer
Alliance Study Chair: James A. Martenson, MD
Status: COMPLETED
Study Description
RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who are undergoing radiation therapy to the pelvis. It is not yet known whether octreotide is effective for diarrhea.
PURPOSE: Randomized phase III trial to determine the effectiveness of octreotide in preventing diarrhea in patients who are undergoing radiation therapy to the pelvis.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information